CA3211975A1 - Human fatty-liver model cells for use in screening method - Google Patents

Human fatty-liver model cells for use in screening method Download PDF

Info

Publication number
CA3211975A1
CA3211975A1 CA3211975A CA3211975A CA3211975A1 CA 3211975 A1 CA3211975 A1 CA 3211975A1 CA 3211975 A CA3211975 A CA 3211975A CA 3211975 A CA3211975 A CA 3211975A CA 3211975 A1 CA3211975 A1 CA 3211975A1
Authority
CA
Canada
Prior art keywords
cells
vldl
medium
human
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3211975A
Other languages
English (en)
French (fr)
Inventor
Masaki Takahashi
Masakazu KAKUNI
Nami Yoshikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoenixbio Co Ltd
Original Assignee
Phoenixbio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoenixbio Co Ltd filed Critical Phoenixbio Co Ltd
Publication of CA3211975A1 publication Critical patent/CA3211975A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA3211975A 2021-02-26 2022-02-24 Human fatty-liver model cells for use in screening method Pending CA3211975A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-030911 2021-02-26
JP2021030911 2021-02-26
PCT/JP2022/007494 WO2022181660A1 (ja) 2021-02-26 2022-02-24 スクリーニング方法に使用するためのヒト脂肪肝モデル細胞

Publications (1)

Publication Number Publication Date
CA3211975A1 true CA3211975A1 (en) 2022-09-01

Family

ID=83049072

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3211975A Pending CA3211975A1 (en) 2021-02-26 2022-02-24 Human fatty-liver model cells for use in screening method

Country Status (6)

Country Link
US (1) US20250263667A1 (https=)
EP (1) EP4299720A4 (https=)
JP (1) JP7449626B2 (https=)
CN (1) CN116917462A (https=)
CA (1) CA3211975A1 (https=)
WO (1) WO2022181660A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023058657A1 (ja) * 2021-10-04 2023-04-13 株式会社フェニックスバイオ コレステロール不含の高比重リポタンパク質粒子

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3157984B2 (ja) 1994-04-11 2001-04-23 科学技術振興事業団 初代培養肝細胞の継代培養系
CA2146735C (en) 1994-04-11 2007-02-20 Chise Tateno Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes
JP3266766B2 (ja) 1994-08-23 2002-03-18 科学技術振興事業団 ローン性増殖能を有する肝実質細胞とその取得方法、並びにその継代培養方法
JPH0915225A (ja) 1995-04-28 1997-01-17 Tosoh Corp 血清リポタンパク質の分析方法
JP3014322B2 (ja) 1996-05-28 2000-02-28 科学技術振興事業団 小型肝細胞の培養方法
JP3211941B2 (ja) 1996-12-26 2001-09-25 科学技術振興事業団 ヒト小型肝細胞の取得方法と、この細胞の初代培養および継代培養方法
JP2002045087A (ja) 2000-05-19 2002-02-12 Japan Science & Technology Corp キメラ動物
JPWO2007052789A1 (ja) 2005-11-04 2009-04-30 株式会社スカイライト・バイオテック 大血管障害を判別するためのリポタンパク質の分析方法
JP2007228962A (ja) 2006-01-31 2007-09-13 Hiroshima Industrial Promotion Organization ヒト肝細胞キメララットの作製方法
WO2008001614A1 (fr) 2006-06-29 2008-01-03 Hiroshima Industrial Promotion Organization Modèle animalier de stéatohépatite non alcoolique et modèle animalier de stéatose hépatique
AU2012374750B2 (en) 2012-03-27 2017-02-02 National University Corporation Kumamoto University Humanized mouse
KR102089477B1 (ko) * 2012-08-31 2020-03-17 더 가버너스 오브 더 유니버시티 오브 알버타 1차 인간 간세포의 표현형을 갖는 세포를 생성하기 위한 방법 및 조성물
JP2014204713A (ja) 2013-03-21 2014-10-30 秋田県 肝細胞分化ステージを評価する新規測定法
WO2016210163A1 (en) * 2015-06-23 2016-12-29 Colorado State University Research Foundation Engineered model of fibrotic diseases
JP7039045B2 (ja) * 2019-08-26 2022-03-22 株式会社フェニックスバイオ ヒト脂肪肝モデル細胞
JP7379934B2 (ja) 2019-08-26 2023-11-15 マツダ株式会社 車両の後部構造

Also Published As

Publication number Publication date
JP7449626B2 (ja) 2024-03-14
US20250263667A1 (en) 2025-08-21
CN116917462A (zh) 2023-10-20
EP4299720A4 (en) 2025-03-05
JPWO2022181660A1 (https=) 2022-09-01
EP4299720A1 (en) 2024-01-03
WO2022181660A1 (ja) 2022-09-01

Similar Documents

Publication Publication Date Title
US20250179436A1 (en) Human fatty-liver model cells
Lin et al. Identification of novel anti-liver cancer small molecules with better therapeutic index than sorafenib via zebrafish drug screening platform
CN103865871A (zh) 治疗肾功能衰竭的选择性细胞疗法
Feng et al. A role for atypical cadherin Celsr3 in hippocampal maturation and connectivity
Saito et al. Novel technique for visualizing primordial germ cells in sturgeons (Acipenser ruthenus, A. gueldenstaedtii, A. baerii, and Huso huso)
WO2008001614A1 (fr) Modèle animalier de stéatohépatite non alcoolique et modèle animalier de stéatose hépatique
Li et al. Genome-edited skin epidermal stem cells protect mice from cocaine-seeking behaviour and cocaine overdose
Szczerba et al. In vitro culture of chicken circulating and gonadal primordial germ cells on a somatic feeder layer of avian origin
Sun et al. Isolation of ready-made rat microvessels and its applications in effective in vivo vascularization and in angiogenic studies in vitro
US20250263667A1 (en) Human fatty-liver model cells for use in screening method
Choi et al. Experimental applications of in situ liver perfusion machinery for the study of liver disease
Pagliaro et al. Generation of human fetal brain organoids and their CRISPR engineering for brain tumor modeling
KR102684690B1 (ko) Etv2 및 그의 용도
EP4414379A1 (en) Cholesterol-free high-density lipoprotein particles
EP3777528A1 (en) Non-human vertebrate transplanted with human hepatocytes and method for producing same
CN114369573A (zh) 构建原位原发鼻咽癌动物模型的方法
Nnoromele et al. Cell–cell interactions between transplanted retinal organoid cells and recipient tissues
JP4321936B2 (ja) 不死化血管周皮細胞株
US20250388867A1 (en) Composition and method for culturing organoids
KR102174851B1 (ko) Cep41 유전자 결손 제프라피쉬 모델, 이의 용도 및 이를 이용한 치료제 스크리닝 방법
CN102876666B (zh) Rna胞体及其用途
KR102465079B1 (ko) 요로 이행상피세포암 환견에서 분리한 braf 돌연변이를 포함한 종양세포주와 전이암세포주 및 이를 이용한 이종이식 동물모델
Lin et al. Xenotransplantation of Human Umbilical Mesenchymal Stromal Cells Derived from Wharton's Jelly Mitigates Mouse Amyotrophic Lateral Sclerosis
JP5970721B2 (ja) 抑制性神経前駆細胞の増殖、分離、移植、およびこの細胞の増殖促進物質
Yang et al. Zebrafish (Danio rerio) as a viable model to study the blood-brain barrier

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - SMALL

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250129

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250129

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250129

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260423